Pharmaceutical Executive
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
2024 Pharm Exec Top 50 Companies
Jun 14, 2024 · As we noted in last year’s report, Novo Nordisk and Eli Lilly, competing in the lucrative GLP-1 receptor agonist space that, of late, has captivated the US and beyond in weight loss, are knocking loudly on the top-10 door.Both companies, who own the highest market caps, respectively, in pharma, turned in massive growth in our latest Pharma 50.
Pharmaceutical Executive - PharmExec
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
Understanding IDNs and What They Mean to the Pharmaceutical …
Aug 2, 2024 · Integrated Delivery Networks have changed the healthcare landscape over the past decade. Greg Skalicky, president and chief revenue officer at EVERSANA, spoke with Pharmaceutical Executive about the ways that commercialization teams are working with these networks to bring drugs to markets.
Amgen's Novel Weight Loss Drug Shows Potential for Longer …
Feb 6, 2024 · Amgen’s novel weight loss drug candidate maridebart cafraglutide (MariTide) showed significant promise in a Phase I trial (NCT04478708), with data suggesting longer lasting and durable reductions in body weight compared with the popular glucagon-like peptide (GLP)-1 agonists currently on the market—Novo Nordisk’s Wegovy (semaglutide) and Eli …
A Promising Option: Exxua - PharmExec
Aug 16, 2024 · In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
2024Finalists - pharmexec.com
Agency: Avant Healthcare Pharmaceutical Company: UCB Campaign: Make HStory (US HCP Campaign) Agency: ClinicalMind Pharmaceutical Company: TruElastin Laboratories, Inc. Campaign: Pushing the limits of aesthetics Agency: MedTrix Healthcare Pharmaceutical Company: Allergan Medical Institute, An Abbvie Company Campaign: The Virtual Patient Simulator (VPS): A Revolutionary Approach to Aesthetic ...
A Roadmap to Pharma Resilience - PharmExec
Aug 15, 2024 · To safeguard patient access to life-saving medications, pharma companies must prioritize building robust resilience strategies that encompass IT systems, inventory management, risk mitigation, and regulatory compliance.
Biopharma Trends in 2024 and Beyond - PharmExec
Jan 17, 2024 · The Inflation Reduction Act (IRA), mergers and acquisitions, obesity-control drugs, and artificial intelligence (AI) dominated the pharma industry’s headlines in 2023.
Out-licensing Deals Between Chinese Pharma and Global
Jan 19, 2024 · In 2023, we witnessed considerable changes in the Chinese pharmaceutical market, especially a booming market of innovative drugs and out-licensing arrangements between China-based biopharma companies and international firms.